NFKB1 and Parkinson disease: Meanwhile, studies have shown that FLZ, a novel phosphamide derivative, can improve the inflammatory state of the brain in PD mouse models by inhibiting TLR4/MyD88/NF-κB signaling pathway (Zhao et al., 2021a).